medroxyprogesterone acetate

Key facts

INN

medroxyprogesterone acetate

Brand

MEDROXYPROGESTERONE ACETATE

Route

INJECTION

Formulation

INJECTABLE

Originator

Amneal Pharmaceuticals

Related patents

patent

US 12403167

Phenylethanoid glycoside extract from Acanthus ilicifolius L., preparation metho

Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12102688

Immunomodulatory nanofilaments

Expires Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11730741

6-chromanol derivatives for use as a medicament

Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11701338

Use of gTso thal in manufacturing medicament for promotion of MS-275 to cross bl

Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11699503

Methods of identifying and treating patient populations amenable to cancer immun

Expires Mon Jul 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11135154

Medroxyprogesterone acetate injectable compositions and methods of use

Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11033550

Medicament

Expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 10857265

Injectable composition for in-situ repair and regeneration of an injured ligamen

Expires Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is medroxyprogesterone acetate?

medroxyprogesterone acetate (MEDROXYPROGESTERONE ACETATE), is a pharmaceutical active ingredient, associated with Amneal Pharmaceuticals, with approved status in the US.

What is the brand name for medroxyprogesterone acetate?

MEDROXYPROGESTERONE ACETATE is a marketed brand name for medroxyprogesterone acetate. Check FDA Drugs@FDA for the current US label holder.